Literature DB >> 12760641

Recombinant bovine herpesvirus-1 expressing p23 protein of Cryptosporidium parvum induces neutralizing antibodies in rabbits.

Yasuhiro Takashima1, Xuenan Xuan, Isao Kimata, Motohiro Iseki, Yoshikatsu Kodama, Noriko Nagane, Hideyuki Nagasawa, Yasunobu Matsumoto, Takeshi Mikami, Haruki Otsuka.   

Abstract

In order to develop a vaccine against cryptosporidiosis in cattle, we constructed a recombinant bovine herpesvirus-1 (BHV-1) expressing an immunodominant surface protein, p23, of Cryptosporidium parvum sporozoites. In the recombinant virus, the p23 gene under the control of a CAG promoter and a gene coding for an enhanced green fluorescent protein were integrated into the gG gene of BHV-1. Despite a low frequency of homologous recombination, cloning of the recombinants was easy because of the specific fluorescence of the plaques formed by recombinants. These plaques were among the plaques of the nonfluorescent parental virus. All clones selected for fluorescence also contained the p23 gene. In MDBK cells infected with the recombinant BHV-1, the antibody against the p23 protein recognized the p23 protein as an approximately 23-kDa specific band in Western blotting analysis. Rabbits immunized with the recombinant produced IgG against the p23 protein. It was also demonstrated that the sera of immunized rabbits reduced infection of C. parvum sporozoites in HCT-8 cells. The serum of an immunized rabbit reduced infection compared with the normal rabbit serum control. These results indicate that the recombinant BHV-1 induces neutralizing antibodies in rabbits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760641     DOI: 10.1645/0022-3395(2003)089[0276:RBHEPP]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

1.  Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.

Authors:  Alvaro Benitez; Jeffrey W Priest; Humphrey N Ehigiator; Nina McNair; Jan R Mead
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

2.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

3.  Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.

Authors:  Zahra Omidian; Elahe Ebrahimzadeh; Parisa Shahbazi; Zeinab Asghari; Parviz Shayan
Journal:  Parasitol Res       Date:  2013-10-24       Impact factor: 2.289

4.  Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Authors:  Rihua Xu; Honglin Jia; Mohamad Alaa Terkawi; Xuenan Xuan; Heping Zhang
Journal:  Curr Microbiol       Date:  2011-02-20       Impact factor: 2.188

5.  Recombinant Cryptosporidium parvum p23 as a target for the detection of Cryptosporidium-specific antibody in calf sera.

Authors:  Parviz Shayan; Elahe Ebrahimzadeh; Mohamad-Reaza Mokhber-Dezfouli; Sadegh Rahbari
Journal:  Parasitol Res       Date:  2008-08-03       Impact factor: 2.289

Review 6.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.